SlideShare a Scribd company logo
Development of
pharmaceutical
formulations
Application of rheological principles in the
development of pharmaceutical
formulations
[Year]
[Type text] Page 2
Dosage forms need specific flow properties so that they can be placed into a
container, remain stable over time, dispensed, handled and properly applied to the
affected area by patients. This is achieved by considering various physical and
analytical parameters.
RHEOLOGY
Rheology is the science that deals with the deformation of matters under the
influence of applied stresses.
Application of rheological principles has major importance in formulation and
analysis of pharmaceuticals as
 it will directly affect the way a drug is formulated and developed,
 the quality of the raw and finished product,
 the drug efficacy,
 the way a patient adheres to the prescribed drug,
 the physical stability and bioavailability of formulations,
 Overall healthcare cost.
Viscosity
Viscosity is a measure of a fluid’s resistance to flow i.e, the measure of a
substance’s resistance to motion under an applied force.
The following Stokes equation is familiar to most; expressing the rate of
sedimentation of suspended particles over time in a liquid vehicle:
Stokes Equation:
𝒅𝒚
𝒅𝒙
= d2
(pi – pe) g / 18ƞ
This equation estimates the sedimentation rate based on certain physical
characteristics of the suspension. These characteristics include the diameter of
suspended particles (d), acceleration due to gravity (g), density of the particles (ρi )
and external phase (ρe ), and the external vehicle viscosity (η).
[Type text] Page 3
Viscosity, is a characteristic non-Newtonian viscous, is an important material
property that contributes to a fluid’s performance. Thus, fluid pharmaceutical
products do not follow Newtonian flow.
Temperature dependence
Viscosity of a liquid decreases as the temperature increases and fluidity increases
with increase in temperature.
The dependence of viscosity on temperature is expressed by an analogous to an
Arhennius equation of chemical kinetics:
ƞ = AeEvRT
k = Rate constant
A = pre-exponential factor
Ev=activation energy
R=universal gas constant
T =absolute temperature (in Kelvin)
The Ev for the flow has been found to be one third of the energy of vaporization
and it needed a free space for flow. This is because a molecule can turn back and
maneuver in a small spacethan its actual size. More energy is required to break
[Type text] Page 4
bonds and permit flow in liquids composed ofmolecules that are associated
through hydrogen bonds. Thesebonds are broken at high temperature by thermal
movement, and Ev is decreased markedly.
Sedimentation:
Sedimentation means settling of particle (or) floccules occurunder gravitational
force in liquid dosage form.
Sedimentation Parameters:
Sedimentation volume (F) or height (H) for flocculatedsuspensions:
Sedimentation volume is a ratio of the ultimate volume of sediment (Vu) to the
original volume of sediment (VO) before settling.
F = V u / VO
Where, Vu = final or ultimate volume of sediment
Vo = original volume of suspension before settling
Degree of flocculation ( β )
It is the ratio of the sedimentation volume of the flocculated suspension F, to the
sedimentation volume of the deflocculated suspension, F ∞
β = (Vu/Vo) flocculated÷ (Vu/Vo) deflocculated.
The minimum value of ß is 1,when flocculated suspension sedimentation volume is
equal to the sedimentation volume of deflocculated suspension.
SUSPENSIONS
Suspensions are coarse dispersions that are biphasic liquid dosageforms of
medicaments in which the finely divided particles are dispersed in a vehicle.
The advantages of suspensions include,
[Type text] Page 5
 Effective dispensing of hydrophobic drugs
 Avoidance of the use of co-solvents
 Masking of unpleasant taste of drugs
 Easy swallowing for young and elderly patients.
Ideal features of suspensiondosage form
1. The final productshould be physically, chemically, and microbiologically stable.
2. Pharmaceutical suspensionshould be aesthetically pleasing and should also have a
pleasing odour, and taste.
3. The productmust remain sufficiently homogenous for at least the period between
shaking the container and removing the required amount.
4. Suspensions must not be too viscous to pour freely from a bottle or to flow through
a needle syringe (for injectable suspensions).
5. The drug substancemust not recrystallize and/or change its polymorphic form
during storage.
6. Suspended particles should settle slowly and the sediment or creaming produced
on storage, if any, should readily redisperse upon gentle shaking of the container.
7. Parenteral and ophthalmic suspensions should be sterilizable and syringable (for
parenteral suspensions).
Stability of suspensions:
Flow behavior of a suspension system is not only dependent on the dispersed phase
(particle size, shape, morphology, concentration), but also crucially dependent on
the rheology modifiers which are used in pharmaceutical suspensions to enhance
their stability.
Rheologic modifiers
Rheologic modifiers are organic and inorganic coating adds that controlthe
rheological characteristics of liquid formulations. In coating technology, rheology
modifiers are mainly used to provide either pseudoplastic and thixotropic
properties. It includes binders (polymers, oligomers, reactive dilutants), solvents
(organic, aqueous), pigments (organic, inorganic) and fillers and additives
(stabilizers, inhibitors, catalysts).
[Type text] Page 6
Buffer and pH modifying agents:These agents are added to stabilize the
suspensions by controlling the altering pH conditions. Citrate buffer are used to
stabilize suspensions in the range pH 3-5 phosphatebuffers are used to stabilize
suspensions in the range of pH 7-8.
Thickeners/Viscositymodifiers: these agents are used to increase the viscosity of
a suspension without substantially changing its other properties and decreases
sedimentation. They can be hydrophilic colloids or polymers.
Polymers of high molecular weight and composed ofwater-loving functional
groups can greatly help to controlviscosity, rheology and thus, stabilizing the
formulation. However, the interaction of these polymers with an aqueous medium
will crucially depend on the nature of the aqueous medium. E.g., gum acacia, corn
starch.
Flocculating agents:Addition of flocculating agents help to stabilize the
suspension by decreasing inter-particle attraction which helps to prevent
aggregation and caking overtime. Eg, Aluminium chloride is used as a flocculating
agents at concentrations of 0.01%-1%.
Coloring agents:They are added to impart distinctive color to suspension and
improve elegance. Eg, D&C Yellow#10 in Ibuprofen suspension.
Wetting agents:Surfactants or Wetting agents are used in suspension to reduce
the interfacial tension between solid particles and vehicle thereby promoting
wetting and deflocculation of particles. E.g., glycerin.
Preservatives:They are added to prevent microbial growth in formulated
suspensions. Eg, Propylene glycol.
[Type text] Page 7
Ciproxin 250 mg/5 mL granules and solvent for oral suspension
Activeingredient – ciprofloxacin
Used as - Antibiotic, Antiprotozoal medication.
Inactiveingredients:
Sweetening agent - Sucrose/Neotame-3to10% concentration
Flavoring agent - mixed fruit powder (orange, banana, pineapple, strawberry)-0.2
to 1% concentration
Buffering agents – sodium citrate, potassium phosphate, citric acid – 0.2 to 1%
concentration
Suspending agent- Xanthan gum, sodium CMC, hydroxypropyl cellulose-0.1-
0.5% concentration
Suitable solvent- Isopropyl alcohol, methylene chloride, water
Lubricants - magnesium sterate, sodium steryl fumarate 0.05-0.2%
[Type text] Page 8
Other excipients - cellulose, starch, lactose 0-15%
Vehicle - purified water
Co-solvent- glycerin
REFERENCE:
 http://www.sips.org.in/wp-content/uploads/2020/03/SUSPENSION-
_BP103TP.pdf
 file:///C:/Users/VM-MED/Downloads/rheology-in-pharmaceutical-
formulationsa-perspective-2329-6631.1000108%20(2).pdf
 Mastropietro DJ, Nimroozi R, Omidian H (2013) Rheology in
Pharmaceutical Formulations-A Perspective. J Develop Drugs 2: 108.
doi:10.4172/2329-6631.1000108
 Martin’s Physical Pharmacy and Pharmaceutical sciences by Patrick J. Sinko
 Physical pharmaceutics by Manavalan and Ramasamy.
 file:///C:/Users/VM-MED/Downloads/rheology-in-pharmaceutical-
formulationsa-perspective-2329-6631.1000108%20(2).pdf

More Related Content

PPT
0 preformulation (1)
PPTX
Drug stability
PPT
PPTX
Solid state manipulation
PPTX
SOLID DISPERSION TECHNIQUE
PPTX
Drug stability studies
PPTX
Preformulation by Raghul Pharmacist
PPTX
Factors affecting drug degradation
0 preformulation (1)
Drug stability
Solid state manipulation
SOLID DISPERSION TECHNIQUE
Drug stability studies
Preformulation by Raghul Pharmacist
Factors affecting drug degradation

What's hot (20)

PDF
Enhancement of Solubility By Solid Dispersion- Presented By Mr.Ajinkya Nikam...
PPT
Stability of drugs
PPTX
Causes of degradation and potential adverse effect of instability in pharmace...
PPTX
Drug stability studies
PPTX
Drug degradation
PPT
Physicochemical characterization of drugs
PPTX
Physical pharmacy
PPTX
Solid dispersion as a technique for enhancement of
PPTX
Solid dispersion technique
PPTX
Microencapsulation
PPTX
Solublisation technique
PPTX
Mechanism of drug degradation and protection
PPTX
Preformulation
PPTX
Preformulation Studies (Chemical Properties) Industrial Pharmacy 1st
PPTX
Solid dispersion by kamlesh
PPTX
Physico-chemical Properties Affecting Drug Formulation.
PPTX
Drug stability
DOC
Review
PPTX
Methods of Solubility Enhancement
PPTX
Application of preformulation consideration in the development of
Enhancement of Solubility By Solid Dispersion- Presented By Mr.Ajinkya Nikam...
Stability of drugs
Causes of degradation and potential adverse effect of instability in pharmace...
Drug stability studies
Drug degradation
Physicochemical characterization of drugs
Physical pharmacy
Solid dispersion as a technique for enhancement of
Solid dispersion technique
Microencapsulation
Solublisation technique
Mechanism of drug degradation and protection
Preformulation
Preformulation Studies (Chemical Properties) Industrial Pharmacy 1st
Solid dispersion by kamlesh
Physico-chemical Properties Affecting Drug Formulation.
Drug stability
Review
Methods of Solubility Enhancement
Application of preformulation consideration in the development of
Ad

Similar to Development of formula (20)

PPTX
Pharmaceuticals Dispersion theory- Suspension and Emulsion
PPTX
Suspensions .pptx
PPTX
SUSPENSIOns and their utilization in drug industry
PDF
Pharmaceutical Suspension
PPTX
Suspension ppt
PPTX
Pharmaceutical suspensions
PDF
Pharmaceutical suspensions sb
PPTX
Pharmaceutical suspension
PPTX
suspension MIU (1).pptx m
PPTX
5. Biphasic Liquid Dosage Forms-Suspension - Copy.pptx
PPTX
Pharmaceutical oral Suspension
PPTX
Liquid dosage forms Suspension, pharmacy
PPT
SUSPENSIONS.ppt
PPT
Pharmaceutical suspension
PPTX
Stability of suspensions
PDF
Introduction to Suspension Dosage Form on Slideshare by Raj Kumar Mandal
PPT
Suspension
PPTX
Suspension.pptx
PPT
Suspension.siam
PDF
Suspension.pdf
Pharmaceuticals Dispersion theory- Suspension and Emulsion
Suspensions .pptx
SUSPENSIOns and their utilization in drug industry
Pharmaceutical Suspension
Suspension ppt
Pharmaceutical suspensions
Pharmaceutical suspensions sb
Pharmaceutical suspension
suspension MIU (1).pptx m
5. Biphasic Liquid Dosage Forms-Suspension - Copy.pptx
Pharmaceutical oral Suspension
Liquid dosage forms Suspension, pharmacy
SUSPENSIONS.ppt
Pharmaceutical suspension
Stability of suspensions
Introduction to Suspension Dosage Form on Slideshare by Raj Kumar Mandal
Suspension
Suspension.pptx
Suspension.siam
Suspension.pdf
Ad

Recently uploaded (20)

PPTX
Transforming Regulatory Affairs with ChatGPT-5.pptx
PPTX
anaemia in PGJKKKKKKKKKKKKKKKKHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH...
PPTX
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
PPTX
surgery guide for USMLE step 2-part 1.pptx
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PPTX
Fundamentals of human energy transfer .pptx
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PPTX
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
PPTX
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
PPTX
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
DOC
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
PPTX
Neuropathic pain.ppt treatment managment
PPT
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
PPTX
anal canal anatomy with illustrations...
PPT
Obstructive sleep apnea in orthodontics treatment
PPT
OPIOID ANALGESICS AND THEIR IMPLICATIONS
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PPTX
SKIN Anatomy and physiology and associated diseases
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PPTX
Respiratory drugs, drugs acting on the respi system
Transforming Regulatory Affairs with ChatGPT-5.pptx
anaemia in PGJKKKKKKKKKKKKKKKKHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH...
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
surgery guide for USMLE step 2-part 1.pptx
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
Fundamentals of human energy transfer .pptx
MENTAL HEALTH - NOTES.ppt for nursing students
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
Neuropathic pain.ppt treatment managment
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
anal canal anatomy with illustrations...
Obstructive sleep apnea in orthodontics treatment
OPIOID ANALGESICS AND THEIR IMPLICATIONS
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
SKIN Anatomy and physiology and associated diseases
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
Respiratory drugs, drugs acting on the respi system

Development of formula

  • 1. Development of pharmaceutical formulations Application of rheological principles in the development of pharmaceutical formulations [Year]
  • 2. [Type text] Page 2 Dosage forms need specific flow properties so that they can be placed into a container, remain stable over time, dispensed, handled and properly applied to the affected area by patients. This is achieved by considering various physical and analytical parameters. RHEOLOGY Rheology is the science that deals with the deformation of matters under the influence of applied stresses. Application of rheological principles has major importance in formulation and analysis of pharmaceuticals as  it will directly affect the way a drug is formulated and developed,  the quality of the raw and finished product,  the drug efficacy,  the way a patient adheres to the prescribed drug,  the physical stability and bioavailability of formulations,  Overall healthcare cost. Viscosity Viscosity is a measure of a fluid’s resistance to flow i.e, the measure of a substance’s resistance to motion under an applied force. The following Stokes equation is familiar to most; expressing the rate of sedimentation of suspended particles over time in a liquid vehicle: Stokes Equation: 𝒅𝒚 𝒅𝒙 = d2 (pi – pe) g / 18ƞ This equation estimates the sedimentation rate based on certain physical characteristics of the suspension. These characteristics include the diameter of suspended particles (d), acceleration due to gravity (g), density of the particles (ρi ) and external phase (ρe ), and the external vehicle viscosity (η).
  • 3. [Type text] Page 3 Viscosity, is a characteristic non-Newtonian viscous, is an important material property that contributes to a fluid’s performance. Thus, fluid pharmaceutical products do not follow Newtonian flow. Temperature dependence Viscosity of a liquid decreases as the temperature increases and fluidity increases with increase in temperature. The dependence of viscosity on temperature is expressed by an analogous to an Arhennius equation of chemical kinetics: ƞ = AeEvRT k = Rate constant A = pre-exponential factor Ev=activation energy R=universal gas constant T =absolute temperature (in Kelvin) The Ev for the flow has been found to be one third of the energy of vaporization and it needed a free space for flow. This is because a molecule can turn back and maneuver in a small spacethan its actual size. More energy is required to break
  • 4. [Type text] Page 4 bonds and permit flow in liquids composed ofmolecules that are associated through hydrogen bonds. Thesebonds are broken at high temperature by thermal movement, and Ev is decreased markedly. Sedimentation: Sedimentation means settling of particle (or) floccules occurunder gravitational force in liquid dosage form. Sedimentation Parameters: Sedimentation volume (F) or height (H) for flocculatedsuspensions: Sedimentation volume is a ratio of the ultimate volume of sediment (Vu) to the original volume of sediment (VO) before settling. F = V u / VO Where, Vu = final or ultimate volume of sediment Vo = original volume of suspension before settling Degree of flocculation ( β ) It is the ratio of the sedimentation volume of the flocculated suspension F, to the sedimentation volume of the deflocculated suspension, F ∞ β = (Vu/Vo) flocculated÷ (Vu/Vo) deflocculated. The minimum value of ß is 1,when flocculated suspension sedimentation volume is equal to the sedimentation volume of deflocculated suspension. SUSPENSIONS Suspensions are coarse dispersions that are biphasic liquid dosageforms of medicaments in which the finely divided particles are dispersed in a vehicle. The advantages of suspensions include,
  • 5. [Type text] Page 5  Effective dispensing of hydrophobic drugs  Avoidance of the use of co-solvents  Masking of unpleasant taste of drugs  Easy swallowing for young and elderly patients. Ideal features of suspensiondosage form 1. The final productshould be physically, chemically, and microbiologically stable. 2. Pharmaceutical suspensionshould be aesthetically pleasing and should also have a pleasing odour, and taste. 3. The productmust remain sufficiently homogenous for at least the period between shaking the container and removing the required amount. 4. Suspensions must not be too viscous to pour freely from a bottle or to flow through a needle syringe (for injectable suspensions). 5. The drug substancemust not recrystallize and/or change its polymorphic form during storage. 6. Suspended particles should settle slowly and the sediment or creaming produced on storage, if any, should readily redisperse upon gentle shaking of the container. 7. Parenteral and ophthalmic suspensions should be sterilizable and syringable (for parenteral suspensions). Stability of suspensions: Flow behavior of a suspension system is not only dependent on the dispersed phase (particle size, shape, morphology, concentration), but also crucially dependent on the rheology modifiers which are used in pharmaceutical suspensions to enhance their stability. Rheologic modifiers Rheologic modifiers are organic and inorganic coating adds that controlthe rheological characteristics of liquid formulations. In coating technology, rheology modifiers are mainly used to provide either pseudoplastic and thixotropic properties. It includes binders (polymers, oligomers, reactive dilutants), solvents (organic, aqueous), pigments (organic, inorganic) and fillers and additives (stabilizers, inhibitors, catalysts).
  • 6. [Type text] Page 6 Buffer and pH modifying agents:These agents are added to stabilize the suspensions by controlling the altering pH conditions. Citrate buffer are used to stabilize suspensions in the range pH 3-5 phosphatebuffers are used to stabilize suspensions in the range of pH 7-8. Thickeners/Viscositymodifiers: these agents are used to increase the viscosity of a suspension without substantially changing its other properties and decreases sedimentation. They can be hydrophilic colloids or polymers. Polymers of high molecular weight and composed ofwater-loving functional groups can greatly help to controlviscosity, rheology and thus, stabilizing the formulation. However, the interaction of these polymers with an aqueous medium will crucially depend on the nature of the aqueous medium. E.g., gum acacia, corn starch. Flocculating agents:Addition of flocculating agents help to stabilize the suspension by decreasing inter-particle attraction which helps to prevent aggregation and caking overtime. Eg, Aluminium chloride is used as a flocculating agents at concentrations of 0.01%-1%. Coloring agents:They are added to impart distinctive color to suspension and improve elegance. Eg, D&C Yellow#10 in Ibuprofen suspension. Wetting agents:Surfactants or Wetting agents are used in suspension to reduce the interfacial tension between solid particles and vehicle thereby promoting wetting and deflocculation of particles. E.g., glycerin. Preservatives:They are added to prevent microbial growth in formulated suspensions. Eg, Propylene glycol.
  • 7. [Type text] Page 7 Ciproxin 250 mg/5 mL granules and solvent for oral suspension Activeingredient – ciprofloxacin Used as - Antibiotic, Antiprotozoal medication. Inactiveingredients: Sweetening agent - Sucrose/Neotame-3to10% concentration Flavoring agent - mixed fruit powder (orange, banana, pineapple, strawberry)-0.2 to 1% concentration Buffering agents – sodium citrate, potassium phosphate, citric acid – 0.2 to 1% concentration Suspending agent- Xanthan gum, sodium CMC, hydroxypropyl cellulose-0.1- 0.5% concentration Suitable solvent- Isopropyl alcohol, methylene chloride, water Lubricants - magnesium sterate, sodium steryl fumarate 0.05-0.2%
  • 8. [Type text] Page 8 Other excipients - cellulose, starch, lactose 0-15% Vehicle - purified water Co-solvent- glycerin REFERENCE:  http://www.sips.org.in/wp-content/uploads/2020/03/SUSPENSION- _BP103TP.pdf  file:///C:/Users/VM-MED/Downloads/rheology-in-pharmaceutical- formulationsa-perspective-2329-6631.1000108%20(2).pdf  Mastropietro DJ, Nimroozi R, Omidian H (2013) Rheology in Pharmaceutical Formulations-A Perspective. J Develop Drugs 2: 108. doi:10.4172/2329-6631.1000108  Martin’s Physical Pharmacy and Pharmaceutical sciences by Patrick J. Sinko  Physical pharmaceutics by Manavalan and Ramasamy.  file:///C:/Users/VM-MED/Downloads/rheology-in-pharmaceutical- formulationsa-perspective-2329-6631.1000108%20(2).pdf